The FDA's poor oversight of postmarketing studies

被引：0

|

作者：

不详

机构：

来源：

LANCET | 2009年 / 374卷 / 9701期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1568 / 1568

页数：1

相关论文

共 50 条

[1] FDA Oversight of Postmarketing Studies
Kashoki, Mwango
Lee, Cathryn
Stein, Peter
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (12): : 1201 - 1202
[2] FDA's monitoring of postmarketing studies probed
Young, Donna
[J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2006, 63 (16) : 1485 - 1486
[3] GAO: FDA Oversight of Produce Is Poor
Kuehn, Bridget M.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (18): : 2106 - 2107
[4] FDA Increases Focus on Postmarketing Studies
Goozner, Merrill
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (17) : 1302 - U17
[5] FDA's postmarketing review of varenicline and bupropion
[J]. Reactions Weekly, 2009, 1236 (1) : 3 - 3
[6] A review of pregnancy and lactation postmarketing studies required by the FDA
Krastein, Jason
Sahin, Leyla
Yao, Lynne
[J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 (03) : 287 - 297
[7] FDA's Framework for Regulatory Oversight of LDTs
Pathak, Bhagyashri
Terry, Sharon F.
[J]. GENETIC TESTING AND MOLECULAR BIOMARKERS, 2014, 18 (12) : 785 - 786
[8] FDA - ADMINISTRATION AND OVERSIGHT
FINE, SD
[J]. FOOD DRUG COSMETIC LAW JOURNAL, 1972, 27 (05): : 278 - 281
[9] FDA oversight questioned
Mitka, Mike
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (22): : 2611 - 2611
[10] Report criticizes FDA's oversight of DTC ads
不详
[J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2003, 60 (02) : 122 - +

← 1 2 3 4 5 →